University Cancer Center (UCC), Dresden
The DKTK partner location in Dresden has chosen to implement the CentraXX Biobank module (CBB) for its work in oncology. Alongside the headquarters of the German Consortium for Translational Cancer Research (DKTK) in Heidelberg, the Dresden location is one of the seven consortium partners in Germany.
Why was the KAIROS system successful in this competative selection process? The DKTK promotes interdisciplinary cancer research at the interface between basic research and clinical practice, as well as clinical studies on innovative therapy and diagnostic procedures. With the DKTK partner location in Dresden, KAIROS GmbH is thus equipping another “Top Oncological Center” in Germany and once again underscoring its claim to continuously develop CentraXX into one of the leading research portals.